Back to search

Article

Pembrolizumab-associated eosinophilic polyserositis with pericardial involvement during adjuvant therapy for clear cell renal cell carcinoma: a case report and narrative review

2026-03-08

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> : Pembrolizumab is a standard adjuvant option for patients with high-risk clear cell renal cell carcinoma after nephrectomy. Serositis is an uncommon immune-related adverse event under programmed cell death 1/programmed death ligand 1 blockade. Pericardial involvement is the best-characterized serosal compartment, and cohort data suggest a several-fold increas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9463250a-7e9d-5d70-bb8e-59e4ee694dcb
DOI
10.21203/rs.3.rs-8910623/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pembrolizumab-associated eosinophilic polyserositis with pericardial involvement during adjuvant therapy for clear cell renal cell carcinoma: a case report and narrative reviewDOI 10.21203/rs.3.rs-8910623/v1
Select a neighboring publication to make it the new centre.